Connection
Boris Draznin to Insulin, Long-Acting
This is a "connection" page, showing publications Boris Draznin has written about Insulin, Long-Acting.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.568 |
|
|
|
-
Hirsch IB, Draznin B. Transition of Patients to and from Insulin Degludec: A Clinical Challenge. J Clin Endocrinol Metab. 2020 06 01; 105(6).
Score: 0.697
-
Hsia E, Seggelke S, Gibbs J, Hawkins RM, Cohlmia E, Rasouli N, Wang C, Kam I, Draznin B. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab. 2012 Sep; 97(9):3132-7.
Score: 0.401
-
Hsia E, Seggelke SA, Gibbs J, Rasouli N, Draznin B. Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy. Nutr Clin Pract. 2011 Dec; 26(6):714-7.
Score: 0.387
-
Draznin B. Mitogenic action of insulin: friend, foe or 'frenemy'? Diabetologia. 2010 Feb; 53(2):229-33.
Score: 0.084